Lilly is a medicine company turning science into healing to make life better for people around the world.

We’re here to help whether you need information about our medicines and devices or have questions about access and affordability. If you live in the United States and have a question about a Lilly medicine, please choose from the following options.

For more than 145 years, we have worked tirelessly to develop and deliver trusted medicines and diagnostics that meet real needs. Our growing portfolio of medicines includes treatments in the areas of bone muscle joint, cancer, cardiovascular, diabetes, endocrine, immunology, neuroscience and obesity.

Take the next step in your care journey with LillyDirect® for select prescribed Lilly medicines, independent virtual and in-person care options, and online pharmacy solutions.

With stunning star-shaped flowers, lilies add elegance and fragrance to any garden. Enjoy their colorful blooms from spring through the first frost by blending early-blooming, mid-season, and late-blooming lilies into your garden. Learn more about choosing, planting, and growing lilies. Everyone loves lilies!

Lilly Cares Foundation, Inc. (Lilly Cares) is a nonprofit charitable organization that provides prescribed Lilly medications for up to 12 months for free to qualifying U.S. patients. Helping patients with significant financial need receive their prescribed Lilly medications at no cost.

We’ve pulled together a list of 40 different types of lilies with photos, including favorites like Calla lilies and different colored lilies including white ones, purple, orange and more. You’ll even learn about seasonal lilies like the Easter Lily and super fragrant ones like Asiatics.

INDIANAPOLIS, Jan. 15, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh ® (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults.

Feb 28, 2025 · Lilly has submitted supplemental marketing applications for Jaypirca in the post-BTK inhibitor setting for CLL/SLL patients around the globe, including in the U.S. About BRUIN CLL-321 BRUIN CLL-321 is a Phase 3, randomized, open-label study of pirtobrutinib versus investigator's choice of idelalisib plus rituximab (IdelaR) or bendamustine plus ...

Learn more about Lilly’s Weight Management Research or view a complete list of our weight management trials. New medicines are made possible by clinical research volunteers. Search to find a Lilly clinical trial near you. Explore medical research.